JP2018521969A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2018521969A5 JP2018521969A5 JP2017560131A JP2017560131A JP2018521969A5 JP 2018521969 A5 JP2018521969 A5 JP 2018521969A5 JP 2017560131 A JP2017560131 A JP 2017560131A JP 2017560131 A JP2017560131 A JP 2017560131A JP 2018521969 A5 JP2018521969 A5 JP 2018521969A5
- Authority
- JP
- Japan
- Prior art keywords
- virus
- cancer
- pharmaceutical composition
- crystal
- hepatitis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000008194 pharmaceutical composition Substances 0.000 claims 24
- 239000013078 crystal Substances 0.000 claims 18
- 241000700605 Viruses Species 0.000 claims 12
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 claims 8
- 206010028980 Neoplasm Diseases 0.000 claims 6
- 208000032839 leukemia Diseases 0.000 claims 6
- 239000002671 adjuvant Substances 0.000 claims 5
- 201000011510 cancer Diseases 0.000 claims 5
- 239000003814 drug Substances 0.000 claims 5
- 229940124597 therapeutic agent Drugs 0.000 claims 5
- 241000711549 Hepacivirus C Species 0.000 claims 4
- 241000725303 Human immunodeficiency virus Species 0.000 claims 4
- VFLDPWHFBUODDF-FCXRPNKRSA-N curcumin Chemical compound C1=C(O)C(OC)=CC(\C=C\C(=O)CC(=O)\C=C\C=2C=C(OC)C(O)=CC=2)=C1 VFLDPWHFBUODDF-FCXRPNKRSA-N 0.000 claims 4
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 claims 4
- 229960003180 glutathione Drugs 0.000 claims 4
- SUSAGCZZQKACKE-ZXZARUISSA-N (1s,2r)-cyclobutane-1,2-dicarboxylic acid Chemical compound OC(=O)[C@H]1CC[C@H]1C(O)=O SUSAGCZZQKACKE-ZXZARUISSA-N 0.000 claims 3
- 190000008236 carboplatin Chemical compound 0.000 claims 3
- 229960004562 carboplatin Drugs 0.000 claims 3
- 239000000203 mixture Substances 0.000 claims 3
- 241001116389 Aloe Species 0.000 claims 2
- ACTIUHUUMQJHFO-UHFFFAOYSA-N Coenzym Q10 Natural products COC1=C(OC)C(=O)C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UHFFFAOYSA-N 0.000 claims 2
- GHASVSINZRGABV-UHFFFAOYSA-N Fluorouracil Chemical compound FC1=CNC(=O)NC1=O GHASVSINZRGABV-UHFFFAOYSA-N 0.000 claims 2
- 108010024636 Glutathione Proteins 0.000 claims 2
- 241000700721 Hepatitis B virus Species 0.000 claims 2
- 241000724675 Hepatitis E virus Species 0.000 claims 2
- 241000709721 Hepatovirus A Species 0.000 claims 2
- 208000008839 Kidney Neoplasms Diseases 0.000 claims 2
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 claims 2
- 206010060862 Prostate cancer Diseases 0.000 claims 2
- 208000000236 Prostatic Neoplasms Diseases 0.000 claims 2
- 206010038389 Renal cancer Diseases 0.000 claims 2
- 208000005718 Stomach Neoplasms Diseases 0.000 claims 2
- 239000004480 active ingredient Substances 0.000 claims 2
- 235000011399 aloe vera Nutrition 0.000 claims 2
- 239000012736 aqueous medium Substances 0.000 claims 2
- GXJABQQUPOEUTA-RDJZCZTQSA-N bortezomib Chemical compound C([C@@H](C(=O)N[C@@H](CC(C)C)B(O)O)NC(=O)C=1N=CC=NC=1)C1=CC=CC=C1 GXJABQQUPOEUTA-RDJZCZTQSA-N 0.000 claims 2
- 229960001467 bortezomib Drugs 0.000 claims 2
- ACTIUHUUMQJHFO-UPTCCGCDSA-N coenzyme Q10 Chemical compound COC1=C(OC)C(=O)C(C\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UPTCCGCDSA-N 0.000 claims 2
- 235000017471 coenzyme Q10 Nutrition 0.000 claims 2
- 229940110767 coenzyme Q10 Drugs 0.000 claims 2
- 229940109262 curcumin Drugs 0.000 claims 2
- 235000012754 curcumin Nutrition 0.000 claims 2
- 239000004148 curcumin Substances 0.000 claims 2
- VFLDPWHFBUODDF-UHFFFAOYSA-N diferuloylmethane Natural products C1=C(O)C(OC)=CC(C=CC(=O)CC(=O)C=CC=2C=C(OC)C(O)=CC=2)=C1 VFLDPWHFBUODDF-UHFFFAOYSA-N 0.000 claims 2
- 239000003937 drug carrier Substances 0.000 claims 2
- 229960002949 fluorouracil Drugs 0.000 claims 2
- 229960000304 folic acid Drugs 0.000 claims 2
- 235000019152 folic acid Nutrition 0.000 claims 2
- 239000011724 folic acid Substances 0.000 claims 2
- 206010017758 gastric cancer Diseases 0.000 claims 2
- 235000003969 glutathione Nutrition 0.000 claims 2
- 238000001802 infusion Methods 0.000 claims 2
- 238000002347 injection Methods 0.000 claims 2
- 239000007924 injection Substances 0.000 claims 2
- 201000010982 kidney cancer Diseases 0.000 claims 2
- 238000000034 method Methods 0.000 claims 2
- 201000011549 stomach cancer Diseases 0.000 claims 2
- 206010061424 Anal cancer Diseases 0.000 claims 1
- 208000007860 Anus Neoplasms Diseases 0.000 claims 1
- 206010003571 Astrocytoma Diseases 0.000 claims 1
- 206010005003 Bladder cancer Diseases 0.000 claims 1
- 208000003174 Brain Neoplasms Diseases 0.000 claims 1
- 206010006187 Breast cancer Diseases 0.000 claims 1
- 208000026310 Breast neoplasm Diseases 0.000 claims 1
- 206010008342 Cervix carcinoma Diseases 0.000 claims 1
- 206010009944 Colon cancer Diseases 0.000 claims 1
- 201000003075 Crimean-Congo hemorrhagic fever Diseases 0.000 claims 1
- 241000725619 Dengue virus Species 0.000 claims 1
- 241001115402 Ebolavirus Species 0.000 claims 1
- 206010014733 Endometrial cancer Diseases 0.000 claims 1
- 206010014759 Endometrial neoplasm Diseases 0.000 claims 1
- 208000000461 Esophageal Neoplasms Diseases 0.000 claims 1
- 206010051066 Gastrointestinal stromal tumour Diseases 0.000 claims 1
- 241001479210 Human astrovirus Species 0.000 claims 1
- 241000701806 Human papillomavirus Species 0.000 claims 1
- 241000702617 Human parvovirus B19 Species 0.000 claims 1
- 206010023927 Lassa fever Diseases 0.000 claims 1
- 206010058467 Lung neoplasm malignant Diseases 0.000 claims 1
- 206010025323 Lymphomas Diseases 0.000 claims 1
- 241001115401 Marburgvirus Species 0.000 claims 1
- 241000712079 Measles morbillivirus Species 0.000 claims 1
- 208000003445 Mouth Neoplasms Diseases 0.000 claims 1
- 208000034578 Multiple myelomas Diseases 0.000 claims 1
- 241000711386 Mumps virus Species 0.000 claims 1
- 241000714209 Norwalk virus Species 0.000 claims 1
- 201000010133 Oligodendroglioma Diseases 0.000 claims 1
- 241000702259 Orbivirus Species 0.000 claims 1
- 206010031096 Oropharyngeal cancer Diseases 0.000 claims 1
- 206010057444 Oropharyngeal neoplasm Diseases 0.000 claims 1
- 206010033128 Ovarian cancer Diseases 0.000 claims 1
- 206010061535 Ovarian neoplasm Diseases 0.000 claims 1
- 206010061902 Pancreatic neoplasm Diseases 0.000 claims 1
- 208000002606 Paramyxoviridae Infections Diseases 0.000 claims 1
- 206010035226 Plasma cell myeloma Diseases 0.000 claims 1
- 241000711798 Rabies lyssavirus Species 0.000 claims 1
- 208000006265 Renal cell carcinoma Diseases 0.000 claims 1
- 241000725643 Respiratory syncytial virus Species 0.000 claims 1
- 241000702670 Rotavirus Species 0.000 claims 1
- 241000710799 Rubella virus Species 0.000 claims 1
- 241000315672 SARS coronavirus Species 0.000 claims 1
- 241000700584 Simplexvirus Species 0.000 claims 1
- 208000000453 Skin Neoplasms Diseases 0.000 claims 1
- 206010041067 Small cell lung cancer Diseases 0.000 claims 1
- 208000024313 Testicular Neoplasms Diseases 0.000 claims 1
- 206010057644 Testis cancer Diseases 0.000 claims 1
- 208000024770 Thyroid neoplasm Diseases 0.000 claims 1
- 208000007097 Urinary Bladder Neoplasms Diseases 0.000 claims 1
- 208000006105 Uterine Cervical Neoplasms Diseases 0.000 claims 1
- 241000700647 Variola virus Species 0.000 claims 1
- 208000036142 Viral infection Diseases 0.000 claims 1
- 241000710886 West Nile virus Species 0.000 claims 1
- 241000710772 Yellow fever virus Species 0.000 claims 1
- 201000011165 anus cancer Diseases 0.000 claims 1
- 201000010881 cervical cancer Diseases 0.000 claims 1
- 208000029742 colonic neoplasm Diseases 0.000 claims 1
- 239000003246 corticosteroid Substances 0.000 claims 1
- 229960001334 corticosteroids Drugs 0.000 claims 1
- 210000002919 epithelial cell Anatomy 0.000 claims 1
- 201000004101 esophageal cancer Diseases 0.000 claims 1
- 201000011243 gastrointestinal stromal tumor Diseases 0.000 claims 1
- 208000005017 glioblastoma Diseases 0.000 claims 1
- 201000010536 head and neck cancer Diseases 0.000 claims 1
- 208000014829 head and neck neoplasm Diseases 0.000 claims 1
- 208000006454 hepatitis Diseases 0.000 claims 1
- 231100000283 hepatitis Toxicity 0.000 claims 1
- 201000011061 large intestine cancer Diseases 0.000 claims 1
- 208000012987 lip and oral cavity carcinoma Diseases 0.000 claims 1
- 201000007270 liver cancer Diseases 0.000 claims 1
- 208000014018 liver neoplasm Diseases 0.000 claims 1
- 201000005202 lung cancer Diseases 0.000 claims 1
- 208000020816 lung neoplasm Diseases 0.000 claims 1
- 208000015486 malignant pancreatic neoplasm Diseases 0.000 claims 1
- 201000009020 malignant peripheral nerve sheath tumor Diseases 0.000 claims 1
- 201000001441 melanoma Diseases 0.000 claims 1
- 206010027191 meningioma Diseases 0.000 claims 1
- 208000029974 neurofibrosarcoma Diseases 0.000 claims 1
- 208000002154 non-small cell lung carcinoma Diseases 0.000 claims 1
- 201000006958 oropharynx cancer Diseases 0.000 claims 1
- 201000008968 osteosarcoma Diseases 0.000 claims 1
- 201000002528 pancreatic cancer Diseases 0.000 claims 1
- 208000008443 pancreatic carcinoma Diseases 0.000 claims 1
- MBWXNTAXLNYFJB-NKFFZRIASA-N phylloquinone Chemical compound C1=CC=C2C(=O)C(C/C=C(C)/CCC[C@H](C)CCC[C@H](C)CCCC(C)C)=C(C)C(=O)C2=C1 MBWXNTAXLNYFJB-NKFFZRIASA-N 0.000 claims 1
- 208000015347 renal cell adenocarcinoma Diseases 0.000 claims 1
- 201000000849 skin cancer Diseases 0.000 claims 1
- 208000000587 small cell lung carcinoma Diseases 0.000 claims 1
- 239000002904 solvent Substances 0.000 claims 1
- 206010041823 squamous cell carcinoma Diseases 0.000 claims 1
- 208000017572 squamous cell neoplasm Diseases 0.000 claims 1
- 238000003756 stirring Methods 0.000 claims 1
- 201000003120 testicular cancer Diseases 0.000 claims 1
- 201000002510 thyroid cancer Diseases 0.000 claims 1
- 208000029729 tumor suppressor gene on chromosome 11 Diseases 0.000 claims 1
- 241000701161 unidentified adenovirus Species 0.000 claims 1
- 241000712461 unidentified influenza virus Species 0.000 claims 1
- 201000005112 urinary bladder cancer Diseases 0.000 claims 1
- 230000009385 viral infection Effects 0.000 claims 1
- 229940051021 yellow-fever virus Drugs 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562163256P | 2015-05-18 | 2015-05-18 | |
| US62/163,256 | 2015-05-18 | ||
| PCT/US2016/032856 WO2016187191A1 (en) | 2015-05-18 | 2016-05-17 | A pharmaceutical co-crystal and use thereof |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2018521969A JP2018521969A (ja) | 2018-08-09 |
| JP2018521969A5 true JP2018521969A5 (enExample) | 2019-06-13 |
| JP6851989B2 JP6851989B2 (ja) | 2021-03-31 |
Family
ID=57320544
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017560131A Expired - Fee Related JP6851989B2 (ja) | 2015-05-18 | 2016-05-17 | 医薬用共結晶及びその用途 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US10751318B2 (enExample) |
| EP (1) | EP3297624B1 (enExample) |
| JP (1) | JP6851989B2 (enExample) |
| KR (1) | KR20180008594A (enExample) |
| CN (1) | CN108135877B (enExample) |
| AU (1) | AU2016265922B2 (enExample) |
| BR (1) | BR112017024727A2 (enExample) |
| CA (1) | CA2986136A1 (enExample) |
| WO (1) | WO2016187191A1 (enExample) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2016187191A1 (en) | 2015-05-18 | 2016-11-24 | Medoc Pharmaceutical Co., Ltd. | A pharmaceutical co-crystal and use thereof |
| CA2988989A1 (en) | 2015-06-19 | 2016-12-22 | Syn-Nat Products Enterprise LLC | Composition containing carboplatin and use |
| WO2016205785A1 (en) | 2015-06-19 | 2016-12-22 | Syn-Nat Products Enterprise LLC | Pharmaceutical composition of carboplatin based co-crystals and use thereof |
| JP6929234B2 (ja) * | 2015-06-25 | 2021-09-01 | シン−ナット プロダクツ エンタープライズ エルエルシー | 医薬共結晶組成物及びその用途 |
| CN109053808B (zh) * | 2017-06-21 | 2020-12-29 | 宋勤华 | 一种高纯度双环铂针状晶体的工业化制备方法 |
| CN111356454B (zh) * | 2017-11-21 | 2023-04-07 | 湖南湘源美东医药科技有限公司 | 含有双环铂的组合产品、其制备方法及其用途 |
| CN116217628B (zh) * | 2023-05-08 | 2023-07-14 | 华东理工常熟研究院有限公司 | 奥沙利铂Pt(IV)配合物的共晶及其制备方法 |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3290365A (en) * | 1963-06-21 | 1966-12-06 | Standard Oil Co | Method of preparing cis-cyclobutane-1, 2-dicarboxylic acid |
| US5455270A (en) * | 1993-08-11 | 1995-10-03 | Bristol-Myers Squibb Co. | Stabilized solutions of platinum(II) antitumor agents |
| KR100317473B1 (ko) | 1999-05-11 | 2001-12-22 | 이계호 | 신규의 백금(ｉｖ)착제 및 그 제조방법 |
| CN1121380C (zh) * | 2000-03-03 | 2003-09-17 | 北京兴大豪斯科技有限公司 | 一种抗肿瘤的双二羧酸二氨络铂衍生物及其药物组合物 |
| AUPQ641100A0 (en) | 2000-03-23 | 2000-04-15 | Australia Nuclear Science & Technology Organisation | Methods of synthesis and use of radiolabelled platinum chemotherapeutic ag ents |
| AU2002221514A1 (en) * | 2001-11-30 | 2003-06-10 | Huisheng Qu | Supermolecular carboplatinum derivatives, their preparation and pharmaceutical composition containing them as active ingredient and applications of the compositions |
| US7927613B2 (en) | 2002-02-15 | 2011-04-19 | University Of South Florida | Pharmaceutical co-crystal compositions |
| CA2477923C (en) * | 2002-03-01 | 2021-02-23 | University Of South Florida | Multiple-component solid phases containing at least one active pharmaceutical ingredient |
| ATE502635T1 (de) | 2002-08-19 | 2011-04-15 | Pfizer | Kombinationstherapie gegen hyperproliferative erkrankungen |
| WO2004099224A1 (de) * | 2003-05-05 | 2004-11-18 | Universität Regensburg | Carboplatin-artige platin (ii)- komplexe |
| WO2006077424A1 (en) | 2005-01-21 | 2006-07-27 | Astex Therapeutics Limited | Pharmaceutical compounds |
| ZA200806748B (en) * | 2006-01-30 | 2010-01-27 | Platco Technologies Proprietar | Preparation of platinum (II) complexes |
| ES2556677T3 (es) | 2006-08-02 | 2016-01-19 | Sunesis Pharmaceuticals, Inc. | Utilización combinada de ácido (+)-1,4-dihidro-7-[(3S,4S)-3-metoxi-4-(metilamino)-1-pirrolidinil]-4-oxo-1-(2-tiazolil)-1,8-naftiridin-3-carboxílico y citarabina (Ara-C) para el tratamiento de la leucemia |
| WO2010029577A2 (en) | 2008-09-15 | 2010-03-18 | Ganga Raju Gokaraju | Anti-cancer drugs and uses relating thereto for metastatic malignant melanoma and other cancers |
| CZ302618B6 (cs) * | 2009-09-10 | 2011-08-03 | Univerzita Palackého | Cyklobutan-1,1-dikarboxylátokomplexy platiny s deriváty N6-benzyladeninu, zpusoby jejich prípravy a použití techto komplexu jako léciv v protinádorové terapii |
| US20110287110A1 (en) | 2010-04-23 | 2011-11-24 | Mark Wesley Dewhirst | Combination cancer treatment |
| HUE041877T2 (hu) | 2013-10-17 | 2019-06-28 | Vertex Pharma | (S)-N-Metil-8-(1-((2'-metil-[4,5'-bipirimidin]-6-il)amino)propán-2-il)kinolin-4-karboxamid kokristályai és deuterált származékai DNS-PK inhibitorokként |
| EP3285758B1 (en) | 2015-04-22 | 2020-04-08 | Syn-Nat Products Enterprise LLC | Co-crystal composition and its pharmaceutical use |
| WO2016187191A1 (en) | 2015-05-18 | 2016-11-24 | Medoc Pharmaceutical Co., Ltd. | A pharmaceutical co-crystal and use thereof |
| CA2988989A1 (en) | 2015-06-19 | 2016-12-22 | Syn-Nat Products Enterprise LLC | Composition containing carboplatin and use |
| WO2016205785A1 (en) | 2015-06-19 | 2016-12-22 | Syn-Nat Products Enterprise LLC | Pharmaceutical composition of carboplatin based co-crystals and use thereof |
| JP6929234B2 (ja) * | 2015-06-25 | 2021-09-01 | シン−ナット プロダクツ エンタープライズ エルエルシー | 医薬共結晶組成物及びその用途 |
-
2016
- 2016-05-17 WO PCT/US2016/032856 patent/WO2016187191A1/en not_active Ceased
- 2016-05-17 CA CA2986136A patent/CA2986136A1/en not_active Abandoned
- 2016-05-17 BR BR112017024727A patent/BR112017024727A2/pt not_active Application Discontinuation
- 2016-05-17 EP EP16797140.7A patent/EP3297624B1/en active Active
- 2016-05-17 US US15/574,015 patent/US10751318B2/en active Active
- 2016-05-17 KR KR1020177035836A patent/KR20180008594A/ko not_active Ceased
- 2016-05-17 CN CN201680028846.3A patent/CN108135877B/zh active Active
- 2016-05-17 JP JP2017560131A patent/JP6851989B2/ja not_active Expired - Fee Related
- 2016-05-17 AU AU2016265922A patent/AU2016265922B2/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2018521969A5 (enExample) | ||
| JP2018504379A5 (enExample) | ||
| JP2014503525A5 (enExample) | ||
| RU2477723C2 (ru) | Ингибиторы протеинкиназ (варианты), их применение для лечения онкологических заболеваний и фармацевтическая композиция на их основе | |
| JP2017536344A5 (enExample) | ||
| JP2013056886A5 (enExample) | ||
| JP2013545785A5 (enExample) | ||
| JP2018520147A5 (enExample) | ||
| JP2015505296A5 (enExample) | ||
| JP2014521688A5 (enExample) | ||
| JP2017504635A5 (enExample) | ||
| JP2019512478A5 (enExample) | ||
| JP2017515901A5 (enExample) | ||
| JP2011519854A5 (enExample) | ||
| RU2012103487A (ru) | Ингибирующие jak соединения на основе пиразолопиримидина и способы | |
| JP2013518107A5 (enExample) | ||
| JP2020532547A5 (enExample) | ||
| JP2017537940A5 (enExample) | ||
| JP2014507421A5 (enExample) | ||
| JP2013544804A5 (enExample) | ||
| JP2005036009A5 (enExample) | ||
| JP2013521312A5 (enExample) | ||
| JP2020507589A5 (enExample) | ||
| JP2017517538A5 (enExample) | ||
| JP2010501584A5 (enExample) |